nonenvelop
saffold
virus
present
nine
picornaviru
genotyp
assign
speci
theiloviru
genu
cardioviru
first
defin
put
caus
fever
unknown
origin
child
safv
includ
approxim
kb
positivesens
singlestrand
rna
genom
fig
sinc
first
definit
describ
along
suggest
genotyp
remain
characteris
cell
cultur
gener
known
ineffici
method
routin
viru
detect
use
studi
safv
safv
predict
encod
singl
polyprotein
silico
analysi
suggest
classic
picornaviru
posttransl
proteolyt
cleavag
pattern
ensu
fig
safv
genotyp
identifi
acut
gastroenter
age
case
genotyp
initi
discov
airway
nasopharynx
children
common
cold
otiti
media
pneumonia
interestingli
distinctli
respiratori
human
rhinovirus
hrv
also
found
gut
call
question
automat
assumpt
safv
restrict
caus
age
found
stool
safv
detect
made
nasopharynx
patient
tonsil
pharyng
herpangina
cerebrospin
fluid
specimen
often
accompani
fever
cough
rhinorrhoea
current
safv
describ
orphan
virus
lack
consensu
diseas
associ
despit
popul
serolog
evid
past
exposur
therefor
import
examin
rang
diseas
state
ubiquit
viru
establish
link
detect
ill
first
step
develop
assay
detect
viral
variant
implement
other
sought
design
revers
transcriptas
realtim
pcr
rtrtpcr
applic
respiratori
tract
specimen
could
concurr
detect
known
safv
genotyp
confirm
use
convent
pcr
genotyp
assay
diagnost
workflow
may
support
enhanc
epidemiolog
studi
worldwid
rtrtpcr
screen
assay
convent
genotyp
rtpcr
assay
develop
diagnost
assay
target
portion
untransl
region
utr
predict
detect
safv
design
base
publicli
avail
utr
sequenc
align
includ
known
genotyp
rang
unclassifi
safv
sequenc
prepar
geneiou
pro
defin
utr
remain
absent
public
databas
newli
develop
safv
rtrtpcr
employ
oligonucleotid
primer
tibmolbiol
germani
tabl
duallabel
fluorogen
oligoprob
safv
tm
l
onestep
rtpcr
reaction
mix
sensifast
onestep
mix
biolin
australia
includ
rnase
inhibitor
mm
mgcl
l
nucleic
acid
extract
ad
revers
transcrib
min
c
mix
incub
c
min
cycl
round
c
c
use
rotorgen
rgq
qiagen
australia
acquir
fluoresc
data
final
anneal
extens
step
cycl
assay
sensit
determin
use
specif
vitro
transcrib
rna
ivtrna
fig
tabl
creat
base
previous
describ
approach
briefli
ivtrna
subject
two
treatment
dnase
turbo
life
technolog
follow
column
purif
isol
rna
mini
kit
biolin
stock
rna
use
determin
analyt
sensit
assay
test
dilut
seri
last
dilut
yield
posit
result
defin
taken
limit
analyt
sensit
ivtrna
copi
number
calcul
use
optic
densiti
approxim
mass
rna
stock
solut
nm
determin
number
mole
establish
molecular
weight
ivtrna
multipli
avogadro
number
posit
diagnost
result
defin
presenc
sigmoid
curv
cross
arbitrari
threshold
cycl
experi
duplic
nontempl
control
cross
threshold
order
confirm
safv
genotyp
posit
patient
specimen
nucleic
acid
ad
convent
nest
rtpcr
target
underlin
fig
apart
rt
step
round
pcr
cycl
mix
four
round
c
c
c
follow
round
c
c
c
final
extens
incub
c
occur
min
first
round
pcr
contain
mm
mgcl
second
contain
mm
specimen
n
respiratori
viru
test
origin
conveni
popul
inpati
outpati
male
age
two
day
year
mean
year
median
inter
quartil
rang
present
queensland
hospit
symptom
ari
specimen
per
month
fig
mostli
nasopharyng
aspir
specimen
nasopharyng
swab
specimen
test
autumn
specimen
fig
sampl
includ
nasal
swab
n
throat
swab
n
bronchoalveolar
lavag
n
nucleic
acid
extract
previous
describ
associ
viru
detect
sex
singl
versu
multipl
virus
per
specimen
consid
use
conting
tabl
fisher
exact
test
http
result
present
rel
risk
rr
confid
interv
ci
signific
level
set
p
specif
safv
rtrtpcr
evalu
use
clinic
specimen
previous
test
found
posit
commonli
consid
respiratori
virus
crossreact
virus
assay
analyt
sensit
rna
copi
per
l
reaction
assay
linear
across
log
dynam
rang
fig
rtrtpcr
identifi
distinct
case
safv
case
fever
report
present
one
case
coincid
sore
throat
headach
neck
stiff
diarrhoea
vomit
five
case
abl
genotyp
four
genbank
access
number
three
latter
may
relat
mismatch
observ
primer
safv
genotyp
lower
viral
load
rna
polymeras
promot
regionunderlin
sa
senseantisens
primer
round
senseantisens
primer
set
round
senseantisens
nest
primer
set
type
specimen
c
valu
three
untyp
specimen
c
valu
safv
detect
made
winter
spring
maydecemb
fig
n
safvposit
specimen
children
two
year
age
younger
age
group
compris
entir
specimen
popul
specimen
age
group
time
like
older
patient
posit
safv
risk
fail
attain
statist
signific
vs
rr
ci
p
specimen
male
time
like
femal
posit
safv
vs
rr
ci
p
half
safv
detect
n
presenc
anoth
viru
vs
rr
ci
p
similar
greater
number
safv
detect
made
influenza
c
viru
n
n
n
coronaviru
n
n
n
detect
appar
present
use
safvrtrtpcr
identifi
cocircul
two
genotyp
respiratori
tract
young
children
around
brisban
australia
assay
import
tool
augment
cultur
serolog
fig
dynam
rang
sensit
yintercept
safv
rtrtpcr
threshold
cycl
ct
plot
initi
ivtrna
copi
number
ivtrna
dilut
amplifi
three
distinct
occas
time
use
fresh
dilut
ivtrna
stock
dilut
test
triplic
error
bar
repres
one
standard
deviat
convent
sybr
green
rtrt
pcr
method
underpin
safv
detect
date
assay
perform
safv
genotyp
lack
utr
sequenc
public
databas
undefin
utr
sequenc
may
repres
type
remain
evalu
safv
rtrtpcr
design
broad
reactiv
identifi
singl
safv
type
circul
csf
children
contain
mismatch
assay
sought
minimis
may
certain
safv
genotyp
impart
tissuespecif
pathogen
much
research
requir
investig
theori
commonli
use
pcr
document
one
safv
genotyp
airway
assay
concurr
identifi
airway
children
believ
assay
like
detect
safv
characteris
utr
permit
better
understand
role
safv
human
diseas
studi
fund
queensland
children
foundat
project
grant
